Spanberger Calls For Boost In Domestic Prescription Drug Manufacturing, Lower Costs For Consumers
October 27, 2022
October 27, 2022
HENRICO, Virginia, Oct. 27 -- Rep. Abigail Spanberger, D-Virginia, issued the following news release and letter on Oct. 26, 2022:
Following new investments in manufacturing research authorized as part of the CHIPS and Science Act, U.S. Representative Abigail Spanberger today called for increased investments to strengthen continuous prescription drug manufacturing, bolster the supply of essential generic medicines, and prevent future prescription drug shortages in the United States.< . . .
Following new investments in manufacturing research authorized as part of the CHIPS and Science Act, U.S. Representative Abigail Spanberger today called for increased investments to strengthen continuous prescription drug manufacturing, bolster the supply of essential generic medicines, and prevent future prescription drug shortages in the United States.< . . .